LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 286

Search options

  1. Book ; Online ; Conference proceedings: Resistance Vessels: Physiology, Pharmacology and Hypertensive Pathology

    Mulvany, M.J.

    Workshop on Resistance Vessel Abnormalities in Hypertension, Sønderborg, June 1984: Proceedings

    (Progress in Applied Microcirculation ; Vol.8)

    1985  

    Series title Progress in Applied Microcirculation ; Vol.8
    Keywords Cardiovascular System ; Angiology ; Microcirculation ; Pathology ; Pharmacology ; Physiology
    Language English
    Size 1 Online-Ressource (X + 236 S.)
    Publisher S. Karger
    Publishing place Basel
    Document type Book ; Online ; Conference proceedings
    HBZ-ID HT019542977
    ISBN 978-3-318-04067-8 ; 3-318-04067-3
    Database ZB MED Catalogue: Medicine, Health, Nutrition, Environment, Agriculture

    More links

    Kategorien

  2. Article ; Online: Obtaining the Best Possible Medication History at Hospital Admission: Description of a Pharmacy Technician-Driven Program to Identify Medication Discrepancies.

    Kabir, Rubiya / Liaw, Samantha / Cerise, Jane / Yi, Jungen / Mulvany, Colm / Qiu, Michael / Beizer, Judith L / Sinvani, Liron D

    Journal of pharmacy practice

    2021  Volume 36, Issue 1, Page(s) 19–26

    Abstract: Purpose: Describe the process of obtaining the best possible medication history (BPMH) by Certified Pharmacy Technicians (CPhTs) on hospital admission to identify medication discrepancies.: Methods: Cross-sectional, descriptive study conducted ... ...

    Abstract Purpose: Describe the process of obtaining the best possible medication history (BPMH) by Certified Pharmacy Technicians (CPhTs) on hospital admission to identify medication discrepancies.
    Methods: Cross-sectional, descriptive study conducted between December 2016 and June 2017 at a quaternary center in New York, including all patients 18 years and older admitted to the medicine service through the Emergency Department (ED) and seen by a CPhT. CPhTs obtained the BPMH using a systematic approach involving a standardized interview, checking medications with secondary sources and updating the electronic health record (EHR). Medication discrepancies were identified and categorized by type and risk. Summary statistics were provided as average and standard deviation (SD) for continuous variables, and as frequencies and percentages for categorical variables. Multivariable regression was used to test for associations between patient factors and presence of a medication discrepancy.
    Results: Of the 3,087 patient visits, the average age was 69 (SD 17.8), 54% were female (n = 1652) and 65% white (n = 2017); comorbidity score breakdown was: 0 (25%, n = 757), 1-2 (33%, n = 1023), 3-4 (23%, n = 699), > 4 (20%, n = 608). The average number of home and discharge medications were 10 (SD 6.1) and 10 (SD 5.4), respectively. The average time spent obtaining the BPMH was 30.6 minutes (SD 12.9). 69% of patients (n = 2130) had at least 1 discrepancy with an average of 4.2 (SD 4.6), of which 43% (n = 920) included high-risk medications. Having a medication discrepancy was associated with a higher number of home medications (p < 0.0001) comorbidities (p < 0.0001), and source of information (p < 0.04).
    Conclusion: Obtaining the BPMH by CPhTs on hospital admission frequently identifies medication discrepancies. Further studies are needed to evaluate the association between obtaining the BPMH and clinical outcomes.
    MeSH term(s) Humans ; Female ; Aged ; Male ; Medication Reconciliation ; Pharmacy Technicians ; Cross-Sectional Studies ; Hospitalization ; Hospitals
    Language English
    Publishing date 2021-06-03
    Publishing country United States
    Document type Journal Article
    ZDB-ID 1027474-1
    ISSN 1531-1937 ; 0897-1900
    ISSN (online) 1531-1937
    ISSN 0897-1900
    DOI 10.1177/08971900211021254
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Patterns of alcohol use among early head and neck cancer survivors: A cross-sectional survey study using the alcohol use disorders identification test (AUDIT).

    Teckie, Sewit / Wotman, Michael / Marziliano, Allison / Orner, David / Yi, Jungen / Mulvany, Colm / Ghaly, Maged / Parashar, Bhupesh / Diefenbach, Michael A

    Oral oncology

    2021  Volume 119, Page(s) 105328

    Abstract: Objective: Alcohol use among survivors of head and neck cancer (HNC) negatively impacts patient outcomes and is an important risk factor for recurrent and second primary tumors. Despite recommendations from several cancer societies, alcohol consumption ... ...

    Abstract Objective: Alcohol use among survivors of head and neck cancer (HNC) negatively impacts patient outcomes and is an important risk factor for recurrent and second primary tumors. Despite recommendations from several cancer societies, alcohol consumption remains a common problem in this population.
    Methods: A cross-sectional study was performed with the Alcohol Use Disorders Identification Test (AUDIT) Self-Report questionnaire. Patients with HNC completed surveys at pre-treatment and follow-up appointments every 3-6 months for at least 2-years after treatment.
    Results: 796 surveys were available for analysis. Most participants were male (75.7%) and had either oropharyngeal (34.5%) or laryngeal (16.7%) cancer. The percentage of alcohol drinkers decreased from 56.1% at pre-treatment to 40.4% at 0-3 months post-treatment, but then increased and surpassed baseline levels by 24 + months post-treatment (64.4%, p = 0.0079). Concurrently, moderate drinkers (AUDIT = 1 - 3) decreased from 34.2% at pre-treatment to 25.2% at 0-3 months post-treatment, but then increased and surpassed baseline levels at 24 + months post-treatment (39.7%, p = 0.0129). Trends among heavy (AUDIT > 3), and heaviest (AUDIT > 6) drinkers were similar, but not statistically significant. At 24 + months post-therapy, we observed a statistically significant increase in female users (39.1% to 63.2%, p = 0.0213) and moderate drinkers < 55 years old (43.4% to 61.9%, p = 0.0184).
    Conclusion: Alcohol consumption in survivors of HNC transiently decreases in the immediate months after treatment, but then increases and remains largely stable by 24 months. This pattern is particularly concerning and highlights the need for timely interventions.
    MeSH term(s) Alcohol Drinking/epidemiology ; Alcoholism/complications ; Alcoholism/epidemiology ; Cancer Survivors ; Cross-Sectional Studies ; Female ; Head and Neck Neoplasms/epidemiology ; Head and Neck Neoplasms/therapy ; Humans ; Male ; Middle Aged ; Neoplasm Recurrence, Local ; Surveys and Questionnaires
    Language English
    Publishing date 2021-05-30
    Publishing country England
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 1120465-5
    ISSN 1879-0593 ; 0964-1955 ; 1368-8375
    ISSN (online) 1879-0593
    ISSN 0964-1955 ; 1368-8375
    DOI 10.1016/j.oraloncology.2021.105328
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Patterns and outcomes of prescribing venous thromboembolism prophylaxis in hospitalized older adults: a retrospective cohort study.

    Goldin, Mark / Cohen, Jessica / Makhnevich, Alex / Mulvany, Colm / Akerman, Meredith / Sinvani, Liron

    Journal of thrombosis and thrombolysis

    2018  Volume 45, Issue 3, Page(s) 369–376

    Abstract: Venous thromboembolism (VTE) is a major cause of morbidity and mortality in the United States. Hospitalized, medically ill older adults have increased risk; despite guidelines, data suggest suboptimal pharmacologic prophylaxis rates. Factors influencing ... ...

    Abstract Venous thromboembolism (VTE) is a major cause of morbidity and mortality in the United States. Hospitalized, medically ill older adults have increased risk; despite guidelines, data suggest suboptimal pharmacologic prophylaxis rates. Factors influencing provider prescribing non-compliance are unclear. We aimed to describe VTE prophylaxis practices and identify risk factors for, and outcomes of, prescribing non-compliance. A retrospective study was conducted of hospitalized adults aged ≥ 75 years, admitted to the medicine service of a large academic tertiary center from May 1, 2014 to June 30, 2015. The primary outcome was non-compliance, defined as the absence of an order for VTE prophylaxis for the duration of hospitalization or an interruption of prophylaxis exceeding 24 h. Secondary measures included in-hospital mortality, length of stay (LOS), and 30-day readmissions. Of 3751 patients (mean age 84.7 years), 97.6% of charts had prophylaxis orders; 11.0% showed non-compliance. Pharmacologic prophylaxis was prescribed in 83.3% of patients and mechanical prophylaxis alone in 14.3%. Factors associated with non-compliance included: higher body mass index (BMI) (p = 0.04), myocardial infarction (p = 0.01), congestive heart failure (p = 0.001), metastatic tumor (p = 0.01). Low mobility was not significantly associated with compliance. Subcutaneous unfractionated heparin was associated with compliance (p < 0.0001); warfarin (p < 0.0001), heparin infusion (p < 0.0001) and low-molecular-weight heparin (p < 0.0001) with non-compliance. Non-compliance was associated with increased mortality (p = 0.01), LOS (p < 0.0001), readmissions (p = 0.0004). Known VTE risk factors (mobility, BMI, comorbidities) were not associated with prescriber compliance patterns. Integrating risk assessment models into provider practice may improve compliance.
    MeSH term(s) Aged ; Aged, 80 and over ; Anticoagulants/therapeutic use ; Female ; Hospitalization ; Humans ; Length of Stay ; Male ; Medication Adherence ; Premedication ; Retrospective Studies ; Risk Assessment ; Risk Factors ; Venous Thromboembolism/drug therapy ; Venous Thromboembolism/mortality ; Venous Thromboembolism/prevention & control
    Chemical Substances Anticoagulants
    Language English
    Publishing date 2018-01-10
    Publishing country Netherlands
    Document type Journal Article
    ZDB-ID 1230645-9
    ISSN 1573-742X ; 0929-5305
    ISSN (online) 1573-742X
    ISSN 0929-5305
    DOI 10.1007/s11239-018-1611-8
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Arterial stiffness and peripheral vascular resistance in offspring of hypertensive parents: influence of sex and other confounders.

    Buus, Niels Henrik / Carlsen, Rasmus K / Khatir, Dinah S / Eiskjær, Hans / Mulvany, Michael J / Skov, Karin

    Journal of hypertension

    2018  Volume 36, Issue 4, Page(s) 815–823

    Abstract: ... LVMI (94 ± 3 vs. 80 ± 2 g/m, P < 0.01), central SBP (121 ± 2 vs. 111 ± 2 mmHg, P < 0.01) and AIx (16.0 ... 0.2 m/s), Rrest (53 ± 3 vs. 51 ± 3 mmHg/ml/min/100 ml) and log Rmin (0.58 ± 0.02 vs. 0.55 ± 0.02 ... remained elevated in DHyPP patients [4.2% (0.7; 7.7), P = 0.02 and 6.3 g/m (0.7; 11.9), P = 0.03 ...

    Abstract Aim: Established essential hypertension is associated with increased arterial stiffness and peripheral resistance, but the extent of vascular changes in persons genetically predisposed for essential hypertension is uncertain.
    Methods: Participants from the Danish Hypertension Prevention Project (DHyPP) (both parents hypertensive) (n = 95, 41 ± 1 years, 53% men) were compared with available spouses (n = 45, 41 ± 1 years) using measurements of ambulatory blood pressure (BP), left ventricular mass index (LVMI), pulse wave velocity, central BP and augmentation index (AIx) in addition to forearm resting and minimal resistance [forearm resting vascular resistance (Rrest) and forearm minimal vascular resistance (Rmin)].
    Results: DHyPP patients with participating spouses had higher 24-h mean BP (94 ± 1 vs. 88 ± 1 mmHg, P < 0.01), LVMI (94 ± 3 vs. 80 ± 2 g/m, P < 0.01), central SBP (121 ± 2 vs. 111 ± 2 mmHg, P < 0.01) and AIx (16.0 ± 1.2 vs. 10.5 ± 1.7%, P < 0.01), but similar carotid-femoral pulse wave velocity (7.5 ± 0.2 vs. 7.1 ± 0.2 m/s), Rrest (53 ± 3 vs. 51 ± 3 mmHg/ml/min/100 ml) and log Rmin (0.58 ± 0.02 vs. 0.55 ± 0.02 mmHg/ml/min/100 ml) when compared with spouses. Using multiple linear regression analysis (adjusting for sex, age, BMI, creatinine clearance and 24-h BP, heart rate and sodium excretion) AIx and LVMI remained elevated in DHyPP patients [4.2% (0.7; 7.7), P = 0.02 and 6.3 g/m (0.7; 11.9), P = 0.03]. For the entire DHyPP cohort AIx, Rrest and Rmin were higher in women than men (P < 0.01), and the same was true for AIx and Rmin among spouses (P < 0.05). Furthermore, AIx was linearly associated with Rrest and Rmin.
    Conclusion: Young to middle-aged individuals genetically predisposed for essential hypertension display increased AIx and LVMI, although vascular stiffness and peripheral resistance are still normal.
    MeSH term(s) Adult ; Blood Pressure ; Blood Pressure Monitoring, Ambulatory ; Echocardiography ; Essential Hypertension/genetics ; Female ; Forearm/blood supply ; Genetic Predisposition to Disease ; Heart Ventricles/diagnostic imaging ; Heart Ventricles/pathology ; Humans ; Male ; Organ Size ; Parents ; Pulse Wave Analysis ; Sex Factors ; Vascular Resistance/genetics ; Vascular Stiffness/genetics
    Language English
    Publishing date 2018-01-05
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 605532-1
    ISSN 1473-5598 ; 0263-6352 ; 0952-1178
    ISSN (online) 1473-5598
    ISSN 0263-6352 ; 0952-1178
    DOI 10.1097/HJH.0000000000001645
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Positive effects of aggressive vasodilator treatment of well-treated essential hypertensive patients.

    Engholm, M / Mulvany, M J / Eftekhari, A / Mathiassen, O N / Buus, N H / Christensen, K L

    Journal of human hypertension

    2016  Volume 30, Issue 11, Page(s) 690–696

    Abstract: Increased systemic vascular resistance and coronary microvascular dysfunction are well-documented in essential hypertension (EH). We investigated the effect of additional vasodilating treatment on coronary and peripheral resistance circulation in EH ... ...

    Abstract Increased systemic vascular resistance and coronary microvascular dysfunction are well-documented in essential hypertension (EH). We investigated the effect of additional vasodilating treatment on coronary and peripheral resistance circulation in EH patients with high systemic vascular resistance index (SVRI) despite well-treated blood pressure (BP). We enroled patients on stable antihypertensive treatment that were given intensified vasodilating therapy (ACE inhibitor, angiotensin II receptor blocker or calcium channel blocker). Before and following 6 months of intensified therapy, coronary resting and maximal artery flow were measured by transthoracic Doppler echocardiography to calculate coronary flow reserve (CFR) and minimum vascular resistance (C-R
    MeSH term(s) Adult ; Aged ; Aged, 80 and over ; Angiotensin II Type 1 Receptor Blockers/adverse effects ; Angiotensin II Type 1 Receptor Blockers/therapeutic use ; Angiotensin-Converting Enzyme Inhibitors/adverse effects ; Angiotensin-Converting Enzyme Inhibitors/therapeutic use ; Antihypertensive Agents/adverse effects ; Antihypertensive Agents/therapeutic use ; Blood Pressure/drug effects ; Calcium Channel Blockers/adverse effects ; Calcium Channel Blockers/therapeutic use ; Coronary Circulation/drug effects ; Drug Therapy, Combination ; Echocardiography, Doppler ; Essential Hypertension/diagnosis ; Essential Hypertension/drug therapy ; Essential Hypertension/physiopathology ; Female ; Forearm/blood supply ; Humans ; Male ; Microcirculation/drug effects ; Middle Aged ; Plethysmography ; Prospective Studies ; Time Factors ; Treatment Outcome ; Vascular Resistance/drug effects ; Vasodilation/drug effects ; Vasodilator Agents/adverse effects ; Vasodilator Agents/therapeutic use
    Chemical Substances Angiotensin II Type 1 Receptor Blockers ; Angiotensin-Converting Enzyme Inhibitors ; Antihypertensive Agents ; Calcium Channel Blockers ; Vasodilator Agents
    Language English
    Publishing date 2016-03-10
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 639472-3
    ISSN 1476-5527 ; 0950-9240
    ISSN (online) 1476-5527
    ISSN 0950-9240
    DOI 10.1038/jhh.2016.13
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article: Vascular remodelling of resistance vessels: can we define this?

    Mulvany, M J

    Cardiovascular research

    1999  Volume 41, Issue 1, Page(s) 9–13

    MeSH term(s) Adaptation, Physiological ; Cardiovascular System/pathology ; Cardiovascular System/physiopathology ; Humans ; Hypertension/pathology ; Hypertension/physiopathology ; Vascular Resistance
    Language English
    Publishing date 1999-01
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Review
    ZDB-ID 80340-6
    ISSN 1755-3245 ; 0008-6363
    ISSN (online) 1755-3245
    ISSN 0008-6363
    DOI 10.1016/s0008-6363(98)00289-2
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Chronic perinatal hypoxia delays cardiac maturation in a mouse model for cyanotic congenital heart disease.

    Romanowicz, Jennifer / Guerrelli, Devon / Dhari, Zaenab / Mulvany, Colm / Reilly, Marissa / Swift, Luther / Vasandani, Nimisha / Ramadan, Manelle / Leatherbury, Linda / Ishibashi, Nobuyuki / Posnack, Nikki Gillum

    American journal of physiology. Heart and circulatory physiology

    2021  Volume 320, Issue 5, Page(s) H1873–H1886

    Abstract: Compared with acyanotic congenital heart disease (CHD), cyanotic CHD has an increased risk of lifelong mortality and morbidity. These adverse outcomes may be attributed to delayed cardiomyocyte maturation, since the transition from a hypoxic fetal milieu ...

    Abstract Compared with acyanotic congenital heart disease (CHD), cyanotic CHD has an increased risk of lifelong mortality and morbidity. These adverse outcomes may be attributed to delayed cardiomyocyte maturation, since the transition from a hypoxic fetal milieu to oxygen-rich postnatal environment is disrupted. We established a rodent model to replicate hypoxic myocardial conditions spanning perinatal development, and tested the hypothesis that chronic hypoxia impairs cardiac development. Pregnant mice were housed in hypoxia beginning at
    MeSH term(s) Age Factors ; Animals ; Animals, Newborn ; Chronic Disease ; Cyanosis/etiology ; Cyanosis/genetics ; Cyanosis/metabolism ; Cyanosis/physiopathology ; Disease Models, Animal ; Female ; Fetal Heart/growth & development ; Fetal Heart/metabolism ; Fetal Hypoxia/complications ; Fetal Hypoxia/genetics ; Fetal Hypoxia/metabolism ; Fetal Hypoxia/physiopathology ; Gene Expression Regulation, Developmental ; Gestational Age ; Heart Defects, Congenital/etiology ; Heart Defects, Congenital/genetics ; Heart Defects, Congenital/metabolism ; Heart Defects, Congenital/physiopathology ; Heart Rate ; Hypoxia/complications ; Hypoxia/genetics ; Hypoxia/metabolism ; Hypoxia/physiopathology ; Mice ; Myocardial Contraction ; Myocytes, Cardiac/metabolism ; Organogenesis ; Pregnancy ; Prenatal Exposure Delayed Effects
    Language English
    Publishing date 2021-03-19
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, U.S. Gov't, Non-P.H.S.
    ZDB-ID 603838-4
    ISSN 1522-1539 ; 0363-6135
    ISSN (online) 1522-1539
    ISSN 0363-6135
    DOI 10.1152/ajpheart.00870.2020
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article: Effects of angiotensin-converting enzyme inhibition on vascular remodeling of resistance vessels in hypertensive patients.

    Mulvany, M J

    Metabolism: clinical and experimental

    1998  Volume 47, Issue 12 Suppl 1, Page(s) 20–23

    Abstract: Essential hypertension is known to be associated with a decrease in the lumen diameter and an increase in the wall thickness to lumen diameter ratio of the resistance vessels. Recently, it has been clarified that this alteration does not necessarily ... ...

    Abstract Essential hypertension is known to be associated with a decrease in the lumen diameter and an increase in the wall thickness to lumen diameter ratio of the resistance vessels. Recently, it has been clarified that this alteration does not necessarily involve vascular growth, but could be due to a rearrangement of the same amount of material, a phenomenon now termed "eutrophic remodeling." These changes are found both in human essential hypertension and in animal models of genetic hypertension. Antihypertensive treatment with angiotensin-converting enzyme (ACE) inhibitors causes a dose-dependent regression of the media to lumen ratio in rats. Clinical studies have now confirmed these findings, showing that when previously untreated essential hypertensive patients are treated with the ACE inhibitor perindopril (PE), the abnormal structure of resistance vessels regresses toward normal values; in contrast, treatment with a beta-blocker does not affect the abnormal vascular structure. The available evidence thus indicates that ACE inhibitors are able to normalize the abnormal resistance vessel structure in essential hypertension, and suggest that this effect may not only be dependent on their ability to reduce blood pressure. This review summarizes these findings, and discusses the extent to which this is desirable.
    MeSH term(s) Angiotensin-Converting Enzyme Inhibitors/therapeutic use ; Animals ; Blood Pressure/physiology ; Blood Vessels/drug effects ; Blood Vessels/pathology ; Blood Vessels/physiopathology ; Humans ; Hypertension/drug therapy ; Hypertension/pathology ; Hypertension/physiopathology ; Vascular Resistance/physiology
    Chemical Substances Angiotensin-Converting Enzyme Inhibitors
    Language English
    Publishing date 1998-12
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Review
    ZDB-ID 80230-x
    ISSN 1532-8600 ; 0026-0495
    ISSN (online) 1532-8600
    ISSN 0026-0495
    DOI 10.1016/s0026-0495(98)90366-3
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Basal cell carcinoma of the vulva: a case series.

    Mulvany, Nicholas J / Rayoo, Mukta / Allen, David G

    Pathology

    2012  Volume 44, Issue 6, Page(s) 528–533

    Abstract: Aims: To review the diagnostic features and characteristics of an uncommon tumour, basal cell carcinoma (BCC) of the vulva.: Methods: The clinical and pathological details of six vulvar BCCs were reviewed. Four of the BCCs arose in isolation, one was ...

    Abstract Aims: To review the diagnostic features and characteristics of an uncommon tumour, basal cell carcinoma (BCC) of the vulva.
    Methods: The clinical and pathological details of six vulvar BCCs were reviewed. Four of the BCCs arose in isolation, one was combined with vulvar Paget's disease and another was intimately associated with a poorly differentiated squamous cell carcinoma.
    Results: The average age of the six patients was 76 years (75 years for 'isolated' BCC; 78 years for BCC 'mixed' with other lesions). The duration of symptoms averaged 13 months in 'isolated' BCC but 24 months in 'mixed' BCC. Vulvar pruritus was the most common presenting complaint in the four cases of 'isolated' BCC. The initial biopsies included shave (× 2) or punch biopsies (× 4). Definitive surgery included excisional biopsy (× 2) or a wide local excision (× 3). In the five assessable tumours, the maximum tumour diameter averaged 19.8 mm (range 11-36 mm). In the sixth patient the BCC was contiguous with a 70 mm, unresectable, poorly differentiated squamous cell carcinoma which was treated by radiotherapy alone.
    Conclusions: : Although the histological diagnosis of vulvar BCC was straightforward in some of our cases, others presented difficulties due to non-representative initial biopsies, insufficient clinical information or contiguity with lesions of greater clinical significance such as Paget's disease or squamous cell carcinoma.
    MeSH term(s) Aged ; Aged, 80 and over ; Carcinoma, Basal Cell/pathology ; Carcinoma, Basal Cell/surgery ; Carcinoma, Squamous Cell/pathology ; Carcinoma, Squamous Cell/surgery ; Female ; Humans ; Middle Aged ; Neoplasms, Multiple Primary/pathology ; Neoplasms, Multiple Primary/surgery ; Paget Disease, Extramammary/pathology ; Paget Disease, Extramammary/surgery ; Treatment Outcome ; Vulva/pathology ; Vulva/surgery ; Vulvar Neoplasms/pathology ; Vulvar Neoplasms/surgery
    Language English
    Publishing date 2012-10
    Publishing country England
    Document type Case Reports ; Journal Article
    ZDB-ID 7085-3
    ISSN 1465-3931 ; 0031-3025
    ISSN (online) 1465-3931
    ISSN 0031-3025
    DOI 10.1097/PAT.0b013e328357a001
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top